Literature DB >> 2852953

Atrial natriuretic factor R1 receptor from bovine adrenal zona glomerulosa: purification, characterization, and modulation by amiloride.

S Meloche1, N McNicoll, B Liu, H Ong, A De Léan.   

Abstract

The atrial natriuretic factor (ANF) R1 receptor from bovine adrenal zona glomerulosa was solubilized with Triton X-100 and purified 13,000-fold, to apparent homogeneity, by sequential affinity chromatography on ANF-agarose and steric exclusion high-performance liquid chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and silver staining of the purified receptor preparation in the absence or presence of dithiothreitol revealed a single protein band of Mr 130,000. Affinity cross-linking of 125I-ANF to the purified receptor resulted in the labeling of the Mr 130,000 band. The purified receptor bound ANF with a specific activity of 6.8 nmol/mg of protein, corresponding to a stoichiometry of 0.9 mol of ANF bound/mol of Mr 130,000 polypeptide. Starting with 500 g of adrenal zona glomerulosa tissue, we obtained more than 500 pmol of purified receptor with an overall yield of 9%. The purified receptor showed a typical ANF-R1 pharmacological specificity similar to that of the membrane-bound receptor. The homogeneous Mr 130,000 receptor protein displayed high guanylate cyclase activity [1.4 mumol of cyclic GMP formed min-1 (mg of protein)-1] which was not stimulated by ANF. This finding supports the notion that the ANF binding and the guanylate cyclase activities are intrinsic components of the same polypeptide. Finally, the purified ANF-R1 receptor retained its sensitivity to modulation by amiloride, suggesting the presence of an allosteric binding site for amiloride on the receptor protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2852953     DOI: 10.1021/bi00421a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  35 in total

Review 1.  Natriuretic peptide receptor: structure and signaling.

Authors:  Kunio S Misono
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

Review 2.  Evolution of the membrane guanylate cyclase transduction system.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

3.  A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling.

Authors:  R M Goraczniak; T Duda; R K Sharma
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

4.  Differential internalization and processing of atrial-natriuretic-factor B and C receptor in PC12 cells.

Authors:  A Rathinavelu; G E Isom
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

5.  Differential regional expression of three natriuretic peptide receptor genes within primate tissues.

Authors:  J N Wilcox; A Augustine; D V Goeddel; D G Lowe
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

6.  Ubiquitous and bifunctional 180 kDa atrial natriuretic factor-dependent guanylate cyclase.

Authors:  R B Marala; R K Sharma
Journal:  Mol Cell Biochem       Date:  1991-01-16       Impact factor: 3.396

7.  Atrial natriuretic factor receptor guanylate cyclase signaling: new ATP-regulated transduction motif.

Authors:  Teresa Duda; Shashank Bharill; Ireneusz Wojtas; Prem Yadav; Ignacy Gryczynski; Zygmunt Gryczynski; Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2009-01-10       Impact factor: 3.396

8.  Plasma membrane guanylate cyclase is a multimodule transduction system.

Authors:  R K Sharma; T Duda; A Sitaramayya
Journal:  Amino Acids       Date:  1994-06       Impact factor: 3.520

Review 9.  Atrial natriuretic factor-receptor guanylate cyclase signal transduction mechanism.

Authors:  Teresa Duda
Journal:  Mol Cell Biochem       Date:  2009-11-26       Impact factor: 3.396

Review 10.  Membrane guanylate cyclase is a beautiful signal transduction machine: overview.

Authors:  Rameshwar K Sharma
Journal:  Mol Cell Biochem       Date:  2009-12-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.